Editorial: New approaches for the discovery of GPCR ligands

被引：0
作者：
Morales, Paula [1 ]
Scharf, Magdalena M. [2 ]
Johnson, Cory P. [3 ]
Di Pizio, Antonella [4 ,5 ]
Hilger, Daniel [6 ]
机构：
[1] CSIC, Inst Quim Med, Madrid, Spain
[2] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden
[3] Kathryn W Davis Ctr Regenerat Biol & Aging, Mt Desert Isl Biol Lab, Bar Harbor, ME 04609 USA
[4] Tech Univ Munich, Sil Biol & Machine Learning, Leibniz Inst Food Syst Biol, Freising Weihenstephan, Germany
[5] Tech Univ Munich, Dept Mol Life Sci, Chemoinformat & Prot Modelling, Freising Weihenstephan, Germany
[6] Philipps Univ Marburg, Dept Pharmaceut Chem, Marburg, Germany
来源：
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
关键词：
GPCR; ligand; modulator; drug discovery; ligand design; new tools; ligand characterization;
D O I：
10.3389/fendo.2023.1272700
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Editorial: Tuberculosis Drug Discovery & Development: Drug Targets, Chemical Matter, and Approaches
    Singh, Vinayak
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [42] Screening for GPCR Ligands Using Surface Plasmon Resonance
    Navratilova, Iva
    Besnard, Jeremy
    Hopkins, Andrew L.
    ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (07): : 549 - 554
  • [43] New methodological approaches to atrial fibrillation drug discovery
    Wong, Chun-Ka
    Tse, Hung-Fat
    EXPERT OPINION ON DRUG DISCOVERY, 2021, 16 (03) : 319 - 329
  • [44] Bioi nformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization
    Colette, Jean
    Ave, Emilie
    Grenier-Boley, Benjamin
    Coquel, Anne-Sophie
    Lesellier, Karine
    Puget, Karine
    JOURNAL OF PEPTIDE SCIENCE, 2007, 13 (09) : 568 - 574
  • [45] Structural basis for GPCR signaling by small polar versus large lipid metabolites-discovery of non-metabolite ligands
    Luckmann, Michael
    Trauelsen, Mette
    Frimurer, Thomas M.
    Schwartz, Thue W.
    CURRENT OPINION IN CELL BIOLOGY, 2020, 63 : 38 - 48
  • [46] The selection and design of GPCR ligands: From concept to the clinic
    Ashton, M
    Charlton, MH
    Schwarz, MK
    Thomas, RJ
    Whittaker, M
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2004, 7 (05) : 441 - 452
  • [47] From Genome to Drugs: New Approaches in Antimicrobial Discovery
    Serral, Federico
    Castello, Florencia A.
    Sosa, Ezequiel J.
    Pardo, Agustin M.
    Palumbo, Miranda Clara
    Modenutti, Carlos
    Palomino, Maria Mercedes
    Lazarowski, Alberto
    Auzmendi, Jeronimo
    Ramos, Pablo Ivan P.
    Nicolas, Marisa F.
    Turjanski, Adrian G.
    Marti, Marcelo A.
    Fernandez Do Porto, Dario
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [48] GPCR heterodimers: asymmetries in ligand binding and signalling output offer new targets for drug discovery
    Goupil, Eugenie
    Laporte, Stephane A.
    Hebert, Terence E.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (05) : 1101 - 1103
  • [49] Modern approaches to accelerate discovery of new antischistosomal drugs
    Neves, Bruno Junior
    Muratov, Eugene
    Machado, Renato Beilner
    Andrade, Carolina Horta
    Lemos Cravo, Pedro Vitor
    EXPERT OPINION ON DRUG DISCOVERY, 2016, 11 (06) : 557 - 567
  • [50] An emerging role for kinase screening in GPCR drug discovery
    Osmond, Ronald I. W.
    Crouch, Michael F.
    Dupriez, Vincent J.
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2010, 12 (03) : 305 - 315
12345